A systematic review and meta-analysis determined that carriers for a mutation to BRCA1, but not BRCA2, have an increased risk of colorectal cancer.
Source: BRCA1 Mutation Observed to Confer Heightened Risk of Colorectal Cancer
Douglas Lowe II MD is Board Certified in Gastroenterology by the American Board of Internal Medicine
Douglas Lowe II MD
Douglas Lowe II MD is a Board Certified Gastroenterologist with Southern Gastroenterology Specialists
